Physician
Rady Children's Hospital San Diego
Rady Children's Hospital San Diego was paid $77.30M by Medicaid between Jan 2018 and Dec 2024, across 589 billing codes. Its largest line is 99215, doctor's office visit, returning patient (complex) — 13% of everything it billed.
33Billing provider infoRADY CHILDREN'S HOSPITAL SAN DIEGO
SAN DIEGO, CA 92123
SAN DIEGO, CA 92123
33aNPI1669617197assigned 12/12/2008
33bProvider typePediatrics Physician
28Total paid$77.30M
24GClaims2,839,299
24DCodes billed589
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in California
Rank by total paid#1 of 1,490
Median peer was paid$15K
This provider vs. median5,156×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 423,566 | $10.41M | |
| 2019 | 459,042 | $10.48M | |
| 2020 | 368,219 | $9.44M | |
| 2021 | 483,005 | $12.22M | |
| 2022 | 481,135 | $10.98M | |
| 2023 | 383,678 | $12.18M | |
| 2024incomplete | 240,654 | $11.60M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 13% | 81,491 | 73,141 | $10.24M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12% | 148,575 | 139,944 | $9.15M |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 5.4% | 25,050 | 23,945 | $4.14M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 4.8% | 141,729 | 140,579 | $3.71M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.2% | 245,040 | 232,374 | $3.21M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.0% | 71,987 | 71,293 | $3.06M |
| Z4305 | 3.9% | 30,243 | 29,427 | $3.01M | |
| Z4306 | 3.9% | 59,918 | 59,581 | $2.98M | |
| 76819 | Fetal biophysical profile; without non-stress testing | 3.7% | 35,527 | 31,624 | $2.89M |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 2.5% | 31,835 | 13,803 | $1.95M |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 2.4% | 21,901 | 21,089 | $1.85M |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 2.3% | 18,234 | 18,133 | $1.75M |
577 more codes
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 2.0% | 26,866 | $1.52M |
| 99203 | Doctor's office visit, new patient (routine) | 1.6% | 35,726 | $1.24M |
| 99480 | Subsequent intensive care, per day, low birth weight infant | 1.6% | 9,382 | $1.21M |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 1.4% | 16,545 | $1.05M |
| 76813 | 1.4% | 10,472 | $1.05M | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.3% | 19,771 | $1.03M |
| Z4304 | 1.3% | 18,746 | $1.00M | |
| 99204 | Doctor's office visit, new patient (more involved) | 1.3% | 17,082 | $995K |
| Z0104 | 1.3% | 6,902 | $978K | |
| 99232 | Hospital visit by a doctor, follow-up day | 1.2% | 18,596 | $929K |
| 99285 | Emergency room visit (most serious) | 1.0% | 11,860 | $807K |
| Z0102 | <1% | 3,838 | $743K | |
| 93320 | <1% | 19,333 | $682K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 12,591 | $681K |
| 76801 | <1% | 8,883 | $654K | |
| 59425 | <1% | 7,887 | $639K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 52,616 | $538K |
| 99243 | <1% | 15,191 | $514K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 9,168 | $478K |
| 93304 | <1% | 10,783 | $472K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 25,246 | $437K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 13,213 | $417K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 9,210 | $416K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 8,186 | $370K |
| 99223 | Prolong inpt eval add15 m | <1% | 4,911 | $358K |
| Z4303 | <1% | 11,726 | $348K | |
| 64642 | <1% | 2,881 | $344K | |
| 64643 | <1% | 2,931 | $343K | |
| 99205 | Prolong outpt/office vis | <1% | 3,621 | $321K |
| 76820 | <1% | 7,543 | $308K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 3,960 | $306K |
| 99460 | <1% | 4,701 | $279K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 11,123 | $277K |
| 93321 | <1% | 14,213 | $269K | |
| 92060 | <1% | 9,349 | $262K | |
| 99469 | Subsequent inpatient neonatal critical care, per day, 28 days or younger | <1% | 1,158 | $226K |
| 95720 | <1% | 989 | $222K | |
| 93325 | <1% | 40,014 | $216K | |
| 99241 | <1% | 5,117 | $211K | |
| 99479 | Subsequent intensive care, per day, very low birth weight infant | <1% | 1,522 | $207K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 3,882 | $206K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 6,421 | $199K |
| 99472 | Subsequent inpatient pediatric critical care, per day, 2-5 years | <1% | 987 | $190K |
| 97750 | <1% | 21,920 | $186K | |
| 92015 | Determination of refractive state | <1% | 34,242 | $185K |
| 99462 | <1% | 5,811 | $179K | |
| 51798 | <1% | 4,966 | $177K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 2,820 | $154K |
| 59025 | Fetal non-stress test | <1% | 11,085 | $142K |
| 31622 | <1% | 1,293 | $139K | |
| 88304 | <1% | 7,816 | $134K | |
| Z4310 | <1% | 15,558 | $129K | |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 7,197 | $122K |
| T4534 | Youth sized disposable incontinence product, protective underwear/pull-on, each | <1% | 811 | $122K |
| 93227 | <1% | 4,610 | $121K | |
| 31526 | <1% | 753 | $113K | |
| J1950 | Injection, leuprolide acetate (for depot suspension), per 3.75 mg | <1% | 15 | $109K |
| 99242 | <1% | 2,048 | $100K | |
| 99234 | <1% | 3,987 | $96K | |
| V2020 | Frames, purchases | <1% | 5,535 | $95K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 8,510 | $91K |
| 51741 | <1% | 5,756 | $90K | |
| 99199 | Unlisted special service, procedure or report | <1% | 6,153 | $84K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 1,268 | $83K |
| 92226 | <1% | 776 | $77K | |
| 51784 | <1% | 2,484 | $76K | |
| 96112 | <1% | 507 | $74K | |
| 17110 | <1% | 4,438 | $74K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 358 | $73K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 838 | $71K |
| 95874 | <1% | 2,652 | $69K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 744 | $63K |
| 92504 | <1% | 4,440 | $61K | |
| 0450 | Emergency room services | <1% | 47,199 | $59K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 25,526 | $55K |
| 88108 | <1% | 2,109 | $53K | |
| 93308 | <1% | 1,483 | $51K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 439 | $51K |
| T4541 | Incontinence product, disposable underpad, large, each | <1% | 1,328 | $50K |
| 88300 | <1% | 10,166 | $49K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 1,268 | $48K |
| 31575 | <1% | 741 | $48K | |
| 88313 | <1% | 1,034 | $47K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 3,310 | $46K |
| 94010 | <1% | 6,647 | $45K | |
| 76825 | <1% | 615 | $44K | |
| A6250 | Skin sealants, protectants, moisturizers, ointments, any type, any size | <1% | 1,556 | $43K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 63,647 | $42K |
| 25600 | <1% | 1,764 | $37K | |
| 92201 | <1% | 1,798 | $37K | |
| 99245 | <1% | 417 | $35K | |
| L4361 | Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf | <1% | 299 | $34K |
| 99254 | <1% | 419 | $32K | |
| 95951 | <1% | 131 | $32K | |
| 62369 | <1% | 885 | $31K | |
| 76827 | <1% | 581 | $30K | |
| 64644 | <1% | 381 | $29K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 24 | $29K |
| 88342 | <1% | 726 | $28K | |
| J0475 | Injection, baclofen, 10 mg | <1% | 33 | $28K |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,606 | $25K |
| 95251 | <1% | 599 | $25K | |
| T4525 | Adult sized disposable incontinence product, protective underwear/pull-on, small size, each | <1% | 268 | $24K |
| 96450 | <1% | 162 | $24K | |
| 80061 | Lipid panel | <1% | 9,644 | $23K |
| 29075 | <1% | 963 | $23K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 391 | $23K |
| 62370 | <1% | 468 | $22K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 571 | $21K |
| 95782 | <1% | 342 | $19K | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 138 | $19K |
| 99255 | <1% | 182 | $19K | |
| 83655 | <1% | 12,647 | $17K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 317 | $17K |
| 99451 | <1% | 1,116 | $16K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 128 | $15K |
| 88307 | <1% | 197 | $14K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,316 | $14K |
| 99417 | Prolong home eval add 15m | <1% | 336 | $13K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 7,365 | $13K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,233 | $12K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 26,787 | $12K |
| 41010 | <1% | 74 | $12K | |
| 96158 | <1% | 173 | $12K | |
| S0265 | Genetic counseling, under physician supervision, each 15 minutes | <1% | 479 | $12K |
| 29425 | <1% | 271 | $12K | |
| 12011 | <1% | 1,335 | $11K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 20,954 | $11K |
| 69210 | <1% | 361 | $11K | |
| 95819 | <1% | 678 | $11K | |
| H2027 | Psychoeducational service, per 15 minutes | <1% | 351 | $11K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 289 | $10K |
| 85060 | <1% | 792 | $10K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 9,850 | $10K |
| 80053 | Comprehensive metabolic panel | <1% | 15,683 | $9K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 5,682 | $9K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 3,221 | $9K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 3,944 | $9K |
| 72082 | <1% | 1,683 | $8K | |
| 99253 | <1% | 147 | $8K | |
| Z4302 | <1% | 970 | $8K | |
| 99356 | <1% | 148 | $8K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 343 | $8K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 5,239 | $7K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 848 | $7K |
| 0760 | <1% | 4,781 | $7K | |
| 97139 | <1% | 55,582 | $7K | |
| 92250 | <1% | 162 | $7K | |
| A4927 | Gloves, non-sterile, per 100 | <1% | 783 | $7K |
| 71045 | Radiologic examination, chest; single view | <1% | 714 | $7K |
| 29065 | <1% | 166 | $6K | |
| 97010 | <1% | 1,584 | $6K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 8,700 | $6K |
| 92225 | <1% | 57 | $6K | |
| 99354 | <1% | 80 | $6K | |
| Z5406 | <1% | 491 | $6K | |
| 99072 | <1% | 24,230 | $6K | |
| 99000 | <1% | 6,061 | $6K | |
| 85018 | <1% | 8,258 | $5K | |
| 97799 | <1% | 29,809 | $5K | |
| T1014 | Telehealth transmission, per minute, professional services bill separately | <1% | 9,268 | $5K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 6,737 | $5K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 2,626 | $5K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,783 | $5K |
| 95873 | <1% | 203 | $5K | |
| Z1034 | <1% | 99 | $5K | |
| V2025 | Deluxe frame | <1% | 59 | $5K |
| A4335 | Incontinence supply; miscellaneous | <1% | 1,571 | $5K |
| 90686 | <1% | 26,390 | $5K | |
| 93790 | <1% | 349 | $5K | |
| 88341 | <1% | 247 | $5K | |
| 92557 | <1% | 4,439 | $5K | |
| 77427 | <1% | 37 | $5K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 980 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 14,321 | $4K |
| 93000 | <1% | 218 | $4K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 2,890 | $4K |
| 12001 | <1% | 718 | $4K | |
| 92588 | <1% | 4,721 | $4K | |
| 95117 | <1% | 950 | $4K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,438 | $4K |
| 87081 | <1% | 15,552 | $4K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,439 | $4K |
| 76770 | <1% | 3,117 | $4K | |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | <1% | 143 | $4K |
| 73110 | <1% | 1,530 | $4K | |
| 76885 | <1% | 95 | $4K | |
| Z4301 | <1% | 211 | $4K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 9,045 | $3K |
| 73630 | <1% | 3,289 | $3K | |
| 96159 | <1% | 140 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 4,096 | $3K |
| 73610 | <1% | 3,628 | $3K | |
| 76937 | <1% | 187 | $3K | |
| 73080 | <1% | 1,383 | $3K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 2,883 | $3K |
| 92523 | <1% | 2,756 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,590 | $3K |
| 84439 | <1% | 3,261 | $3K | |
| 92551 | <1% | 22,795 | $3K | |
| 73090 | <1% | 4,100 | $3K | |
| 96113 | <1% | 49 | $3K | |
| 87088 | <1% | 292 | $3K | |
| 81001 | <1% | 5,598 | $3K | |
| 99070 | <1% | 530 | $3K | |
| 92227 | <1% | 177 | $3K | |
| 81025 | <1% | 3,238 | $3K | |
| 96156 | <1% | 40,564 | $2K | |
| 92567 | <1% | 6,102 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 4,540 | $2K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,581 | $2K |
| 61070 | <1% | 19 | $2K | |
| 99418 | Prolong nursin fac eval 15m | <1% | 52 | $2K |
| 73140 | <1% | 3,064 | $2K | |
| 92511 | <1% | 107 | $2K | |
| 76942 | <1% | 86 | $2K | |
| 99355 | <1% | 30 | $2K | |
| 93975 | <1% | 2,771 | $2K | |
| V2784 | Lens, polycarbonate or equal, any index, per lens | <1% | 12 | $2K |
| 95816 | <1% | 76 | $2K | |
| 73130 | <1% | 2,149 | $2K | |
| 94760 | <1% | 3,975 | $2K | |
| 64640 | <1% | 17 | $2K | |
| 87631 | <1% | 2,250 | $2K | |
| 99173 | <1% | 20,352 | $2K | |
| 92002 | <1% | 43 | $2K | |
| 96160 | <1% | 13,769 | $2K | |
| 82947 | <1% | 5,785 | $2K | |
| 76881 | <1% | 28 | $2K | |
| 73562 | <1% | 1,478 | $2K | |
| 76882 | <1% | 87 | $2K | |
| 26720 | <1% | 425 | $1K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 2,664 | $1K |
| 31231 | <1% | 39 | $1K | |
| 81002 | <1% | 4,084 | $1K | |
| 99252 | <1% | 34 | $1K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 27 | $1K |
| G9920 | Screening performed and negative | <1% | 3,385 | $1K |
| 87040 | <1% | 1,407 | $1K | |
| 73590 | <1% | 1,981 | $1K | |
| 73070 | <1% | 2,073 | $1K | |
| 73564 | <1% | 365 | $1K | |
| 47000 | <1% | 21 | $1K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 752 | $1K |
| 86480 | <1% | 42 | $1K | |
| 85027 | <1% | 5,440 | $1K | |
| 74018 | <1% | 3,440 | $1K | |
| 29125 | <1% | 435 | $976.89 | |
| 94060 | <1% | 190 | $972.37 | |
| 92508 | Group treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 5,839 | $929.91 |
| 85014 | <1% | 1,639 | $915.95 | |
| 73100 | <1% | 2,931 | $899.91 | |
| 25605 | <1% | 70 | $893.40 | |
| 93298 | <1% | 27 | $881.79 | |
| 83690 | <1% | 3,323 | $815.97 | |
| 81015 | <1% | 4,279 | $779.18 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,398 | $762.48 |
| 80076 | <1% | 2,538 | $755.60 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 676 | $747.80 |
| 99358 | Prolong nursin fac eval 15m | <1% | 13 | $745.35 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 1,300 | $728.78 |
| 72170 | <1% | 2,406 | $727.50 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 43,371 | $716.24 |
| 73030 | <1% | 340 | $700.44 | |
| 84702 | <1% | 118 | $648.45 | |
| 87186 | <1% | 3,193 | $648.39 | |
| 97802 | <1% | 1,372 | $641.98 | |
| 85652 | <1% | 5,226 | $641.73 | |
| 93015 | <1% | 12 | $636.72 | |
| 84450 | <1% | 4,358 | $632.79 | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 1,188 | $625.34 |
| 84460 | <1% | 4,702 | $608.72 | |
| 92134 | <1% | 21 | $606.56 | |
| 86140 | <1% | 8,062 | $579.88 | |
| 86003 | <1% | 1,678 | $555.51 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,103 | $539.58 |
| 23500 | <1% | 14 | $530.44 | |
| 86580 | <1% | 171 | $518.40 | |
| 83735 | <1% | 1,230 | $516.86 | |
| 73600 | <1% | 88 | $492.55 | |
| L4350 | Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf | <1% | 766 | $489.30 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,349 | $477.67 |
| 76870 | <1% | 1,154 | $469.13 | |
| 29105 | <1% | 71 | $462.32 | |
| 0250 | <1% | 1,216 | $462.24 | |
| 73000 | <1% | 734 | $446.07 | |
| 94680 | <1% | 41 | $434.66 | |
| 86769 | <1% | 250 | $406.68 | |
| 0272 | <1% | 2,587 | $396.22 | |
| 93016 | <1% | 26 | $392.54 | |
| 73620 | <1% | 552 | $370.35 | |
| 87070 | <1% | 80 | $360.97 | |
| 84436 | <1% | 2,816 | $360.97 | |
| 87486 | <1% | 2,879 | $359.09 | |
| 87581 | <1% | 2,880 | $359.09 | |
| 82728 | <1% | 2,074 | $355.52 | |
| J3535 | Drug administered through a metered dose inhaler | <1% | 279 | $326.17 |
| 82465 | <1% | 474 | $319.92 | |
| 11900 | <1% | 271 | $313.41 | |
| 98960 | <1% | 27 | $303.18 | |
| J3490 | Unclassified drugs | <1% | 9,826 | $299.95 |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 221 | $298.15 |
| 29130 | <1% | 332 | $295.53 | |
| 69200 | <1% | 12 | $293.89 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 228 | $265.82 |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 51 | $263.16 |
| 82784 | <1% | 2,170 | $257.33 | |
| 99221 | <1% | 12 | $252.13 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 6,294 | $248.27 |
| 0270 | <1% | 744 | $247.27 | |
| 99157 | <1% | 250 | $246.38 | |
| 92579 | <1% | 409 | $246.25 | |
| 81000 | <1% | 4,423 | $241.29 | |
| 93018 | <1% | 26 | $240.76 | |
| 85007 | <1% | 1,568 | $239.19 | |
| 99201 | <1% | 769 | $238.21 | |
| 84100 | <1% | 1,140 | $228.67 | |
| 93226 | <1% | 131 | $226.56 | |
| 92700 | <1% | 978 | $225.00 | |
| 97803 | <1% | 1,121 | $224.60 | |
| 83516 | <1% | 1,568 | $220.70 | |
| 84315 | <1% | 50 | $211.84 | |
| 74019 | <1% | 2,766 | $209.40 | |
| 82550 | <1% | 771 | $207.30 | |
| L3260 | Surgical boot/shoe, each | <1% | 271 | $206.64 |
| 82977 | <1% | 3,724 | $201.12 | |
| 94644 | <1% | 522 | $200.38 | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 332 | $199.94 |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 74 | $194.06 |
| 85610 | <1% | 2,317 | $187.03 | |
| 73560 | <1% | 597 | $176.22 | |
| 90461 | <1% | 4,665 | $175.40 | |
| 93225 | <1% | 131 | $173.22 | |
| 96127 | <1% | 5,342 | $171.57 | |
| 75565 | <1% | 13 | $167.53 | |
| 90688 | <1% | 565 | $161.42 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 18 | $160.25 |
| 83540 | <1% | 2,364 | $155.82 | |
| 83550 | <1% | 2,019 | $152.08 | |
| 73660 | <1% | 509 | $147.63 | |
| 85730 | <1% | 1,600 | $144.18 | |
| 3074F | <1% | 1,449 | $143.70 | |
| 0360 | <1% | 8,259 | $142.66 | |
| 72100 | <1% | 294 | $137.37 | |
| 84484 | <1% | 134 | $131.25 | |
| 0271 | <1% | 5,831 | $124.60 | |
| 88311 | <1% | 15 | $124.31 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 203 | $114.60 |
| 83880 | <1% | 72 | $107.72 | |
| 87806 | <1% | 162 | $106.14 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 27 | $105.99 |
| 86901 | <1% | 299 | $103.65 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 29 | $101.40 |
| 99156 | <1% | 31 | $99.30 | |
| 86900 | <1% | 297 | $95.97 | |
| 77072 | <1% | 1,406 | $95.58 | |
| 87045 | <1% | 1,342 | $89.06 | |
| 0710 | <1% | 4,590 | $79.63 | |
| 77073 | <1% | 423 | $79.17 | |
| 87899 | <1% | 654 | $79.04 | |
| 87046 | <1% | 1,338 | $78.99 | |
| 85045 | <1% | 1,142 | $78.92 | |
| 70360 | <1% | 125 | $78.60 | |
| 74455 | <1% | 61 | $75.61 | |
| 83993 | <1% | 478 | $75.40 | |
| 84478 | <1% | 305 | $73.27 | |
| 95115 | <1% | 17 | $64.67 | |
| 82570 | <1% | 1,232 | $58.97 | |
| T4537 | Incontinence product, protective underpad, reusable, bed size, each | <1% | 89 | $58.46 |
| 51701 | <1% | 155 | $55.00 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 192 | $54.17 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,643 | $50.00 |
| 82785 | <1% | 894 | $45.76 | |
| 1036F | <1% | 2,002 | $45.20 | |
| 87071 | <1% | 1,550 | $45.12 | |
| 87015 | <1% | 325 | $43.96 | |
| 72070 | <1% | 66 | $43.78 | |
| 99058 | <1% | 14 | $41.20 | |
| 0002A | <1% | 14 | $40.00 | |
| 93786 | <1% | 54 | $36.97 | |
| 87205 | <1% | 1,342 | $34.92 | |
| 0510 | <1% | 39,793 | $34.10 | |
| 85384 | <1% | 824 | $33.92 | |
| 92552 | <1% | 3,973 | $33.78 | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 362 | $33.00 |
| 1159F | <1% | 1,698 | $32.80 | |
| 90651 | <1% | 395 | $31.00 | |
| 76377 | <1% | 113 | $29.36 | |
| 87338 | <1% | 173 | $27.62 | |
| 73060 | <1% | 82 | $26.15 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 2,250 | $24.67 |
| 0456 | <1% | 30,533 | $23.77 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 448 | $21.37 |
| 87650 | <1% | 14 | $20.60 | |
| A9286 | Hygienic item or device, disposable or non-disposable, any type, each | <1% | 20 | $20.52 |
| 84156 | <1% | 766 | $20.34 | |
| J2704 | Injection, propofol, 10 mg | <1% | 792 | $19.55 |
| 82248 | <1% | 56 | $19.08 | |
| 87503 | <1% | 215 | $18.08 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,167 | $16.97 |
| 51600 | <1% | 61 | $14.50 | |
| 87077 | <1% | 12 | $14.16 | |
| 86376 | <1% | 12 | $13.96 | |
| 82607 | <1% | 126 | $13.03 | |
| 83525 | <1% | 1,036 | $9.87 | |
| 90734 | <1% | 246 | $9.00 | |
| 90670 | <1% | 561 | $9.00 | |
| 90656 | <1% | 502 | $9.00 | |
| 90698 | <1% | 437 | $9.00 | |
| 84550 | <1% | 410 | $8.66 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 360 | $8.55 |
| 87400 | <1% | 447 | $8.12 | |
| 84703 | <1% | 172 | $8.11 | |
| 83615 | <1% | 271 | $7.66 | |
| 80069 | <1% | 66 | $7.49 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 277 | $6.99 |
| 27786 | <1% | 29 | $6.75 | |
| 93788 | <1% | 54 | $6.49 | |
| 90696 | <1% | 12 | $6.00 | |
| 90674 | <1% | 264 | $5.80 | |
| 82310 | <1% | 96 | $4.43 | |
| 90710 | <1% | 15 | $3.00 | |
| 36416 | <1% | 3,985 | $3.00 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 1,829 | $2.64 |
| 81003 | <1% | 103 | $0.78 | |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | <1% | 630 | $0.43 |
| 92582 | 0% | 255 | $0.00 | |
| 0402 | 0% | 240 | $0.00 | |
| 87329 | 0% | 284 | $0.00 | |
| 94664 | 0% | 254 | $0.00 | |
| 0730 | 0% | 31 | $0.00 | |
| S9470 | Nutritional counseling, dietitian visit | 0% | 73 | $0.00 |
| 86644 | 0% | 15 | $0.00 | |
| 99051 | 0% | 68 | $0.00 | |
| S9342 | Home therapy; enteral nutrition via pump; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (enteral formula and nursing visits coded separately), per diem | 0% | 1,140 | $0.00 |
| 0113 | 0% | 768 | $0.00 | |
| 90661 | 0% | 20 | $0.00 | |
| L1830 | Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf | 0% | 78 | $0.00 |
| 0123 | 0% | 642 | $0.00 | |
| 92081 | 0% | 194 | $0.00 | |
| 99367 | 0% | 1,229 | $0.00 | |
| 99053 | 0% | 142 | $0.00 | |
| 1160F | 0% | 391 | $0.00 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 0% | 29 | $0.00 |
| 99499 | 0% | 100,493 | $0.00 | |
| 3078F | 0% | 1,448 | $0.00 | |
| 87101 | 0% | 85 | $0.00 | |
| 73551 | 0% | 224 | $0.00 | |
| 92550 | 0% | 320 | $0.00 | |
| 99188 | 0% | 689 | $0.00 | |
| 84295 | 0% | 97 | $0.00 | |
| 84145 | 0% | 104 | $0.00 | |
| 92555 | 0% | 109 | $0.00 | |
| 99401 | 0% | 65 | $0.00 | |
| 0320 | 0% | 621 | $0.00 | |
| 0302 | 0% | 615 | $0.00 | |
| 90700 | 0% | 173 | $0.00 | |
| 99490 | Ccm add 20min | 0% | 1,715 | $0.00 |
| 84681 | 0% | 117 | $0.00 | |
| 92585 | 0% | 26 | $0.00 | |
| 90715 | 0% | 41 | $0.00 | |
| S9999 | Sales tax | 0% | 75 | $0.00 |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 0% | 187 | $0.00 |
| G9919 | Screening performed and positive and provision of recommendations | 0% | 181 | $0.00 |
| 87328 | 0% | 284 | $0.00 | |
| 90633 | 0% | 148 | $0.00 | |
| 86756 | 0% | 13 | $0.00 | |
| 90707 | 0% | 133 | $0.00 | |
| 99155 | 0% | 32 | $0.00 | |
| 90685 | 0% | 52 | $0.00 | |
| 90713 | 0% | 97 | $0.00 | |
| 0300 | 0% | 27 | $0.00 | |
| 82272 | 0% | 13 | $0.00 | |
| J2941 | Injection, somatropin, 1 mg | 0% | 12 | $0.00 |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | 0% | 36 | $0.00 |
| 86665 | 0% | 73 | $0.00 | |
| 86703 | 0% | 45 | $0.00 | |
| 98970 | 0% | 142 | $0.00 | |
| 87324 | 0% | 24 | $0.00 | |
| 90655 | 0% | 16 | $0.00 | |
| 90648 | 0% | 14 | $0.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 26 | $0.00 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 12 | $0.00 |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 0% | 45 | $0.00 |
| A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | 0% | 15 | $0.00 |
| 99421 | 0% | 15 | $0.00 | |
| 88399 | 0% | 12 | $0.00 | |
| 83970 | 0% | 28 | $0.00 | |
| 87420 | 0% | 13 | $0.00 | |
| 0071A | 0% | 14 | $0.00 | |
| 86645 | 0% | 15 | $0.00 | |
| 54161 | 0% | 13 | $0.00 | |
| 91300 | 0% | 33 | $0.00 | |
| 97039 | 0% | 36 | $0.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 12 | $0.00 |
| 11750 | 0% | 13 | $0.00 | |
| 99442 | 0% | 23 | $0.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 874 | $0.00 |
| 0305 | 0% | 846 | $0.00 | |
| G0378 | Hospital observation service, per hour | 0% | 1,430 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 1,223 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 25 | $0.00 |
| 0258 | 0% | 1,147 | $0.00 | |
| 99174 | 0% | 42 | $0.00 | |
| 92587 | 0% | 521 | $0.00 | |
| 76536 | 0% | 166 | $0.00 | |
| 0636 | 0% | 1,234 | $0.00 | |
| 99441 | 0% | 15 | $0.00 | |
| 97166 | 0% | 2,879 | $0.00 | |
| 97165 | 0% | 95 | $0.00 | |
| 96151 | 0% | 303 | $0.00 | |
| 0301 | 0% | 854 | $0.00 | |
| 97535 | Self-care/home management training, each 15 minutes | 0% | 45 | $0.00 |
| B4160 | Enteral formula, for pediatrics, nutritionally complete calorically dense (equal to or greater than 0.7 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit | 0% | 552 | $0.00 |
| 0306 | 0% | 1,120 | $0.00 | |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | 0% | 309 | $0.00 |
| 86664 | 0% | 71 | $0.00 | |
| 41899 | Unlisted procedure, dentoalveolar structures | 0% | 1,801 | $0.00 |
| 86780 | 0% | 136 | $0.00 | |
| 82150 | 0% | 378 | $0.00 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 0% | 625 | $0.00 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | 0% | 12 | $0.00 |
| 0307 | 0% | 122 | $0.00 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 78 | $0.00 |
| 0370 | 0% | 442 | $0.00 | |
| 76010 | 0% | 66 | $0.00 | |
| 90716 | 0% | 179 | $0.00 | |
| 87181 | 0% | 104 | $0.00 | |
| 99366 | 0% | 456 | $0.00 | |
| 0206 | 0% | 72 | $0.00 | |
| 90744 | 0% | 38 | $0.00 | |
| 72040 | 0% | 103 | $0.00 | |
| S9452 | Nutrition classes, non-physician provider, per session | 0% | 13 | $0.00 |
| 91307 | 0% | 51 | $0.00 | |
| 86308 | 0% | 68 | $0.00 | |
| 87807 | 0% | 40 | $0.00 | |
| 99384 | 0% | 28 | $0.00 | |
| 0410 | 0% | 398 | $0.00 | |
| S9451 | Exercise classes, non-physician provider, per session | 0% | 66 | $0.00 |
| 84132 | 0% | 27 | $0.00 | |
| 3351F | 0% | 137 | $0.00 | |
| 0310 | 0% | 206 | $0.00 | |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 0% | 190 | $0.00 |
| A7015 | Aerosol mask, used with dme nebulizer | 0% | 25 | $0.00 |
| 74010 | 0% | 55 | $0.00 | |
| 1000F | 0% | 13 | $0.00 | |
| 0072A | 0% | 28 | $0.00 | |
| 87147 | 0% | 13 | $0.00 | |
| 1220F | 0% | 149 | $0.00 | |
| 82746 | 0% | 25 | $0.00 | |
| 86850 | 0% | 97 | $0.00 | |
| 99383 | 0% | 27 | $0.00 | |
| 96150 | 0% | 80 | $0.00 | |
| E0570 | Nebulizer, with compressor | 0% | 28 | $0.00 |
| 90620 | 0% | 14 | $0.00 | |
| 82043 | 0% | 53 | $0.00 | |
| D0120 | Dental checkup, returning patient | 0% | 65 | $0.00 |
| 90680 | 0% | 56 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 34 | $0.00 |
| 82330 | 0% | 57 | $0.00 | |
| 90697 | 0% | 12 | $0.00 | |
| 90677 | 0% | 26 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 72 | $0.00 |
| 90480 | 0% | 42 | $0.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 102 | $0.00 |
| 71020 | 0% | 82 | $0.00 | |
| 24530 | 0% | 30 | $0.00 | |
| 28470 | 0% | 15 | $0.00 | |
| S9558 | Home injectable therapy; growth hormone, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem | 0% | 12 | $0.00 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 13 | $0.00 |
| 26600 | 0% | 24 | $0.00 | |
| 82803 | 0% | 13 | $0.00 | |
| 87340 | 0% | 12 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 23 | $0.00 |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | 0% | 18 | $0.00 |
| 4037F | 0% | 24 | $0.00 | |
| S9446 | Patient education, not otherwise classified, non-physician provider, group, per session | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFRIAS, PATRICIO (CHIEF EXECUTIVE OFFICER & PRESIDENT)
Parent organizationRADY CHILDREN'S HOSPITAL SAN DIEGO